GlassScriptPhysician profile
Ronny L Rotondo
NPI 1285948810
$4,023.12
in general payments reported to CMS, 2019-2025
8 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.20 · 2021: $118 · 2023: $243 · 2024: $3,266 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,058 · Travel and Lodging: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,058.23 |
| Travel and Lodging | $752.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iba Proton Therapy, INC. | $1,309.39 | 2023-2024 | |
| Ion Beam Applications S.A. | $1,299.96 | 2019-2024 | |
| Icotec Medical INC. | $1,086.04 | 2024-2025 | Icotec Blackarmor Spine System, Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm |
| Novocure INC. | $227.93 | 2021-2024 | Optune |
| Gt Medical Technologies, INC | $56.60 | 2025 | Gammatile |
| Novo Nordisk INC | $16.97 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.24 | 2019 | |
| Sobi, INC | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronny Rotondo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.